Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05588609
Title Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merus N.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The Oncology Institute of Hope & Innovation Whittier California 90603 United States Details
Florida Cancer Specialists Lake Mary Florida 32746 United States Details
The Center for Cancer and Blood Disorders Bethesda Maryland 20817 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
TriHealth Cancer Institute Cincinnati Ohio 45220 United States Details
University Hospitals - Seidman Cancer Center Cleveland Ohio 44106 United States Details
Northwest Medical Specialties Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field